Starbucks: Analyst Consensus Estimates

Starbucks (NASDAQ: SBUX) will be reporting their fiscal second quarter financial results today after the close of markets. Analysts have a consensus $115.05 12-month price target on the company, via a total of 34 analysts, with ten analysts having strong buy ratings. Nine analysts meanwhile have buy ratings and 15 have hold ratings. The street high is a $137 price target, and the lowest target sits at $82.

24 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 24 analysts is $6.8 billion; this number has been revised upwards from $6.7 billion at the start of the year. The highest revenue estimate is $7.47 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently 17 analysts who have second-quarter EBITDA estimates. The mean is currently $1.27 billion, with this number having been revised down from $1.35 billion at the start of the year. The street high estimate currently sits at $1.36 billion in EBITDA and the lowest is $1.17 billion.

Analysts estimate that quarterly earnings per share will come in at $0.52, with this number being slightly revised down from $0.59 at the start of the year. Street high currently sits at $0.59 in earnings per share, while the lowest estimate is $0.47 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

They Laughed at $3,000 Gold, Now We’re Headed for $4,000! | Sean Roosen – Osisko Development Corp.

Recommended

Steadright Begins Preliminary Economic Assessment On TitanBeach Project

Three Miners Trapped Underground At Newmont’s Red Chris Mine

Related News

Haywood Initiates Coverage On Ascend Wellness With $16.50 Price Target

Haywood Capital Markets recently became the latest firm to initiate coverage on Ascend Wellness (CSE:...

Wednesday, September 1, 2021, 03:33:00 PM

Stifel: Comparing US Cannabis To Traditional CPG Suggests ~20x Upside

On Monday Stifel GMP released their 2021 US Cannabis outlook. Andrew Partheniou, Stifel GMP’s cannabis...

Wednesday, January 6, 2021, 10:48:00 AM

BMO: Dollarama Is “Resilient During Periods Of High Inflation”

On September 9, Dollarama (TSX: DOL) announced its second quarter 2023 financial results. The company...

Thursday, September 15, 2022, 03:41:00 PM

BMO Downgrades Activision Blizzard, Says To “Take Profits, Step To Sidelines”

BMO’s analyst Gerrick Johnson is downgrading Activision Blizzard (NASDAQ: ATVI) to Market Perform and reducing...

Tuesday, October 13, 2020, 04:24:00 PM

Denison Mines: Canaccord’s Take On The JCU Exploration Offer

Earlier this week, Denison Mines Corp. (TSX: DML) announced that they sent an offer to...

Friday, May 7, 2021, 10:15:00 AM